search
Back to results

Cool Baby Oil for Pruritus and Sleep Quality Among Uremic Patients

Primary Purpose

Haemodialysis-Associated Pruritus

Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Baby oil
Placebo
Sponsored by
Alexandria University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Haemodialysis-Associated Pruritus

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Having three episodes of itching (each episode 5 min or longer) within the last 2 weeks
  • Having intermittent itching complaints during the last 6 month
  • Agreed to be on a fixed dose of the medical treatment throughout the study

Exclusion Criteria:

  • Open wound
  • Skin infection
  • Edema
  • History of allergic reaction to the oils
  • Liver and dermatological diseases
  • Usage of other treatment rather than the medical treatment on a regular basis 2 weeks prior to randomization and throughout the study
  • Currently participating in other clinical trials

Sites / Locations

  • Dialysis Units of Almowasah University Hospital
  • Dialysis Units of the Main University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Baby oil

Placebo

Arm Description

A cool commercial baby oil at a temperature between 10°C and 15°C that composed of Paraffinum Liquidum, Isopropyl Palmitate, Parfumwill be applied to the affected area for a period of 15-20 min for three times a week before each hemodialysis session for 12 weeks. the baby oil bottle will be stored at the refrigerator.

A cool distilled water at a temperature between 10°C and 15°C with added two drops of the baby oil to each 100 cc will be applied to the affected area for a period of 15-20 min for three times a week before each hemodialysis session for 12 weeks. the distilled water will be put at an identical bottle as the baby oil bottle and stored at the refrigerator.

Outcomes

Primary Outcome Measures

mean itching severity score at the baseline defined by Itching Severity Scale (ISS)
this scale includes three items; (1) distribution of itching; (2) severity of itching; and (3) sleep disturbance caused by itching. Scores range 2-45. Increasing scores indicate increasing severity and intensity of itching.
change of the mean Itching Severity Scale (ISS) at 4 weeks
this scale includes three items; (1) distribution of itching; (2) severity of itching; and (3) sleep disturbance caused by itching. Scores range 2-45. Increasing scores indicate increasing severity and intensity of itching.
Change of the mean Itching Severity Scale (ISS) at 12 weeks
this scale includes three items; (1) distribution of itching; (2) severity of itching; and (3) sleep disturbance caused by itching. Scores range 2-45. Increasing scores indicate increasing severity and intensity of itching.
Mean pruritus severity Score on Visual Analog Scale at the Baseline
This scale will be used to measure the itching intensity and consisting of a 10cm long line and a single question. The left end point represents "no itch" and the right end point the "worst imaginable itch
Change from baseline mean of the pruritus severity score on the Visual Analog Scale at 4 weeks
This scale will be used to measure the itching intensity and consisting of a 10cm long line and a single question. The left end point represents "no itch" and the right end point the "worst imaginable itch
Change from baseline mean of the pruritus scores on the Visual Analog Scale at 12 weeks
This scale will be used to measure the itching intensity and consisting of a 10cm long line and a single question. The left end point represents "no itch" and the right end point the "worst imaginable itch
Mean score of the sleep quality on the Pittsburgh sleep quality index at the baseline
it measure the self-rated sleep quality over the past month, and it is consisted of 19 self-rated question and 5 question rated by bed partner or roommate. Score ranges from 0 to 21. a score of > 5 indicate poor or difficult sleep and a score of ≤ 5 indicate good-sleep .
Change from baseline mean of the sleep quality on the Pittsburgh sleep quality index at 4 weeks
it measure the self-rated sleep quality over the past month, and it is consisted of 19 self-rated question and 5 question rated by bed partner or roommate. Score ranges from 0 to 21. a score of > 5 indicate poor or difficult sleep and a score of ≤ 5 indicate good-sleep .
Change from baseline mean of the sleep quality on the Pittsburgh sleep quality index at 12 weeks
it measure the self-rated sleep quality over the past month, and it is consisted of 19 self-rated question and 5 question rated by bed partner or roommate. Score ranges from 0 to 21. a score of > 5 indicate poor or difficult sleep and a score of ≤ 5 indicate good-sleep .

Secondary Outcome Measures

socio-demographic and clinical data assessment tool
this tool gathers data about participants' age, gender, educational level, marital status, area of residence, and occupation, duration of disease, comorbidity disease, duration of itching, Concurrent use of antihistamine for itching, period of most intense pruritus.
Related adverse Events
An unfavorable change in the health of a participants that happens during a clinical study or within a 2 days after the study has ended. This change may or may not be caused by the assigned treatment.

Full Information

First Posted
September 22, 2022
Last Updated
January 13, 2023
Sponsor
Alexandria University
search

1. Study Identification

Unique Protocol Identification Number
NCT05555524
Brief Title
Cool Baby Oil for Pruritus and Sleep Quality Among Uremic Patients
Official Title
Effect of Cool Baby Oil on Pruritus and Sleep Quality Among Uremic Patients: a Double-blind Placebo-controlled Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Completed
Study Start Date
October 2, 2022 (Actual)
Primary Completion Date
January 12, 2023 (Actual)
Study Completion Date
January 12, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Alexandria University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study aims to evaluate the effect of cool baby oil on pruritus and sleep quality among uremic patient Research Hypothesis: H01: There is no difference between hemodialysis patients with uremic pruritus who apply cool baby and those who apply placebo regarding sleep quality at 4 weeks follow-up H02: There is no difference between hemodialysis patients with uremic pruritus who apply cool baby and those who apply placebo regarding itching severity at 4 weeks follow-up H03: There is no difference between hemodialysis patients with uremic pruritus who apply cool baby and those who apply placebo regarding sleep quality at 12 weeks follow up H04: There is no difference between hemodialysis patients with uremic pruritus who apply cool baby and those who apply placebo regarding itching severity at 12 weeks follow up H1: Hemodialysis patients with uremic pruritus who apply cool baby oil will exhibit improved sleep quality than those who apply placebo at 4 weeks follow up H2: Hemodialysis patients with uremic pruritus who apply cool baby oil will exhibit decreased itching severity than those who apply placebo at 4 weeks follow up H3: Hemodialysis patients with uremic pruritus who apply cool baby oil will exhibit improved sleep quality than those who apply placebo at 12 weeks follow up H4: Hemodialysis patients with uremic pruritus who apply cool baby oil will exhibit decreased itching severity than those who apply placebo at 12 weeks follow up
Detailed Description
Treatment of uremic pruritus is difficult due to the refractory nature of the disease, resulting in poor hemodialysis patient quality of life, pharmacological therapy is the most common clinical treatment method. Unfortunately, despite these interventions, pruritus remains a chronic problem for many dialysis patients. Recently, non-pharmacological interventions are effective for hemodialysis patients with uremic pruritus. Emollients that include Petrolatum, lanolin, mineral oil, and dimethicone were very effective, readily available, and cost-effective interventions in comparison to other methods to improve pruritus symptoms. Several studies have been conducted and show the efficiency of baby oil in controlling pruritus and enhancing sleep quality among hemodialysis patients. However these studies evaluate the short-term effect (4 weeks), Although these studies employed usual care, no-treatment group as the control condition, thus it was not possible to blind the participants. This type of control group would likely increase treatment effects from baby oil by comparison. Thus the current study will be conducted to evaluate the effect of baby oil on pruritus and sleep quality compared to a placebo control at 4 and 12 weeks followup.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Haemodialysis-Associated Pruritus

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
two-group pre-test and repeated post-test study
Masking
ParticipantOutcomes Assessor
Masking Description
A two computer allocation sequence will be generated. They will be placed in an opaque, sealed envelope and kept with the head nurse of each hemodialysis unit. After completing the baseline data, the clinical researchers open the envelops and assign the patients to one group. The baby oil and the placebo distilled water will be placed on identical bottles and participants will not be informed about group assignments. The clinical researcher will label the groups as A or B; only the clinical researchers will know the group allocation. Both the outcome assessor and the statistician will be blinded.
Allocation
Randomized
Enrollment
80 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Baby oil
Arm Type
Experimental
Arm Description
A cool commercial baby oil at a temperature between 10°C and 15°C that composed of Paraffinum Liquidum, Isopropyl Palmitate, Parfumwill be applied to the affected area for a period of 15-20 min for three times a week before each hemodialysis session for 12 weeks. the baby oil bottle will be stored at the refrigerator.
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
A cool distilled water at a temperature between 10°C and 15°C with added two drops of the baby oil to each 100 cc will be applied to the affected area for a period of 15-20 min for three times a week before each hemodialysis session for 12 weeks. the distilled water will be put at an identical bottle as the baby oil bottle and stored at the refrigerator.
Intervention Type
Other
Intervention Name(s)
Baby oil
Intervention Description
Before each application Hand hygiene will be done Skin care will be done to the affected area and the area is thoroughly dried. Participants will wear a hospital gown and seated comfortably on their bed. Gentle massage with the cool baby oil will be applied on the itching area and is continued for 15-20 min. Message will be applied for three times a week before each hemodialysis session for 12 weeks
Intervention Type
Other
Intervention Name(s)
Placebo
Intervention Description
Before each application Hand hygiene will be done Skin care will be done to the affected area and the area is thoroughly dried. Participants will wear a hospital gown and seated comfortably on their bed. Gentle massage with the cool distilled water will be applied on the itching area and is continued for 15-20 min. Message will be applied for three times a week before each hemodialysis session for 12 weeks
Primary Outcome Measure Information:
Title
mean itching severity score at the baseline defined by Itching Severity Scale (ISS)
Description
this scale includes three items; (1) distribution of itching; (2) severity of itching; and (3) sleep disturbance caused by itching. Scores range 2-45. Increasing scores indicate increasing severity and intensity of itching.
Time Frame
at the baseline (before assigning the participants to the study groups)
Title
change of the mean Itching Severity Scale (ISS) at 4 weeks
Description
this scale includes three items; (1) distribution of itching; (2) severity of itching; and (3) sleep disturbance caused by itching. Scores range 2-45. Increasing scores indicate increasing severity and intensity of itching.
Time Frame
after 4 weeks from the baseline
Title
Change of the mean Itching Severity Scale (ISS) at 12 weeks
Description
this scale includes three items; (1) distribution of itching; (2) severity of itching; and (3) sleep disturbance caused by itching. Scores range 2-45. Increasing scores indicate increasing severity and intensity of itching.
Time Frame
after 12 weeks from the baseline
Title
Mean pruritus severity Score on Visual Analog Scale at the Baseline
Description
This scale will be used to measure the itching intensity and consisting of a 10cm long line and a single question. The left end point represents "no itch" and the right end point the "worst imaginable itch
Time Frame
at the baseline (before assigning the participants to the study groups)
Title
Change from baseline mean of the pruritus severity score on the Visual Analog Scale at 4 weeks
Description
This scale will be used to measure the itching intensity and consisting of a 10cm long line and a single question. The left end point represents "no itch" and the right end point the "worst imaginable itch
Time Frame
after 4 weeks from the baseline
Title
Change from baseline mean of the pruritus scores on the Visual Analog Scale at 12 weeks
Description
This scale will be used to measure the itching intensity and consisting of a 10cm long line and a single question. The left end point represents "no itch" and the right end point the "worst imaginable itch
Time Frame
after 12 weeks from the baseline
Title
Mean score of the sleep quality on the Pittsburgh sleep quality index at the baseline
Description
it measure the self-rated sleep quality over the past month, and it is consisted of 19 self-rated question and 5 question rated by bed partner or roommate. Score ranges from 0 to 21. a score of > 5 indicate poor or difficult sleep and a score of ≤ 5 indicate good-sleep .
Time Frame
at the baseline (before assigning the participants to the study groups)
Title
Change from baseline mean of the sleep quality on the Pittsburgh sleep quality index at 4 weeks
Description
it measure the self-rated sleep quality over the past month, and it is consisted of 19 self-rated question and 5 question rated by bed partner or roommate. Score ranges from 0 to 21. a score of > 5 indicate poor or difficult sleep and a score of ≤ 5 indicate good-sleep .
Time Frame
after 4 weeks from the baseline
Title
Change from baseline mean of the sleep quality on the Pittsburgh sleep quality index at 12 weeks
Description
it measure the self-rated sleep quality over the past month, and it is consisted of 19 self-rated question and 5 question rated by bed partner or roommate. Score ranges from 0 to 21. a score of > 5 indicate poor or difficult sleep and a score of ≤ 5 indicate good-sleep .
Time Frame
after 12 weeks from the baseline
Secondary Outcome Measure Information:
Title
socio-demographic and clinical data assessment tool
Description
this tool gathers data about participants' age, gender, educational level, marital status, area of residence, and occupation, duration of disease, comorbidity disease, duration of itching, Concurrent use of antihistamine for itching, period of most intense pruritus.
Time Frame
(before assigning the participants to the study groups)
Title
Related adverse Events
Description
An unfavorable change in the health of a participants that happens during a clinical study or within a 2 days after the study has ended. This change may or may not be caused by the assigned treatment.
Time Frame
from starting of the intervention till 2 days after study completion

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Having three episodes of itching (each episode 5 min or longer) within the last 2 weeks Having intermittent itching complaints during the last 6 month Agreed to be on a fixed dose of the medical treatment throughout the study Exclusion Criteria: Open wound Skin infection Edema History of allergic reaction to the oils Liver and dermatological diseases Usage of other treatment rather than the medical treatment on a regular basis 2 weeks prior to randomization and throughout the study Currently participating in other clinical trials
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Maha G Asal, Phd
Organizational Affiliation
Alexandria University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Hoda A El-Deeb, Phd
Organizational Affiliation
Alexandria University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Mona A Amer, Phd
Organizational Affiliation
Alexandria University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Mervat A Hawash, Phd
Organizational Affiliation
Alexandria University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dialysis Units of Almowasah University Hospital
City
Alexandria
Country
Egypt
Facility Name
Dialysis Units of the Main University Hospital
City
Alexandria
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
It is not yet known if there will be a plan to make individual participant data available.

Learn more about this trial

Cool Baby Oil for Pruritus and Sleep Quality Among Uremic Patients

We'll reach out to this number within 24 hrs